AI in Oncology Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Increasing Prevalence of Cancer
   3. Market Restraints
      1. Regulatory and Compliance Challenges
      2. High Development and Implementation Costs
   4. Market Opportunity
      1. Growing Adoption Of Precision Medicine
   5. Market Trends
      1. Integration of AI with Multi-Omics Data
      2. Expansion of AI in Genomic Analysis for Personalized Medicine
5. MARKET SEGMENTATION
   1. By Component
      1. Software Solutions
      2. Hardware
      3. Services
   2. By Type of Cancer
      1. Breast Cancer
      2. Lung Cancer
      3. Prostate Cancer
      4. Colorectal Cancer
      5. Brain Tumour
      6. Others
   3. By Application
      1. Diagnostics (Pathology, Cancer Radiology)
      2. Radiation Therapy (Radiotherapy)
      3. Research & Development (Drug design, development process, etc.)
      4. Chemotherapy
      5. Immunotherapy
   4. By End User
      1. Hospitals
      2. Surgical Centres & Medical Institutes
      3. Others (Pharmaceutical companies, Research Institutes & Training Centres)
   5. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Azra AI
      2. ConcertAI
      3. Digital Diagnostics Inc.
      4. GE HealthCare
      5. IBM
      6. Intel Corporation
      7. Median Technologies
      8. NVIDIA Corporation
      9. PathAI
      10. Siemens Healthcare GmbH
7. MARKET OPPORTUNITIES AND FUTURE TREND

Frequently Asked Questions

Q.1. What is the projected market value of the global AI in Oncology market?

The global market of AI in Oncology is projected to reach USD 18.26Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global AI in Oncology market?

The global AI in Oncology market has an estimated annual growth rate of 22.5%.

Q.3. What are the recent trends of AI in Oncology market?

Integration of AI with multi-omics data and expansion of ai in genomic analysis for personalized medicine are some of themajor trends of the market that is projected to boost the market growth in the near future.  

Q.4. Which are the top companies to hold the market share in AI in Oncology?

The major companies profiled in this report include Azra AI, ConcertAI, Digital Diagnostics Inc., GE HealthCare, IBM, Intel Corporation, Median Technologies, NVIDIA Corporation, PathAI, Siemens Healthcare GmbH,among others.  

Q.5. Which is the largest regional market in the AI in Oncology?

North America is the largest regional market for AI in Oncology.